Lead Pharmacist - High Cost Drugs | Hampshire Hospitals NHS Foundation Trust
| Dyddiad hysbysebu: | 27 Tachwedd 2025 |
|---|---|
| Cyflog: | Heb ei nodi |
| Gwybodaeth ychwanegol am y cyflog: | £55,690 - £62,682 Per Annum Pro Rata |
| Oriau: | Rhan Amser |
| Dyddiad cau: | 27 Rhagfyr 2025 |
| Lleoliad: | Winchester, SO22 5DG |
| Cwmni: | Hampshire Hospitals NHS Foundation Trust |
| Math o swydd: | Parhaol |
| Cyfeirnod swydd: | 7444822/251-FCSS4822-PHAR |
Crynodeb
We are in the fortunate position to be able to offer a part-time post for our Lead Pharmacist for High Cost Drugs. This post will involve working closely with national teams to ensure cost-effective use of high cost medication within the trust. An ability to work with various members of the multidisciplinary team will be essential to support access to new technologies for patients.
To lead, develop, deliver and evaluate the process for approval and appropriate use of High Cost Drugs within the Trust.
To liaise with Trust staff, NHSE South pharmacists and other commissioners to ensure that any relevant financial and implementation issues for NICE Technology Appraisal Guidance are identified and articulated at an early stage.
To support the business planning and challenge process for high-cost and specialist medicines and ensure that national commissioning policies and protocols for those high-cost treatments that sit outside of NICE recommendations are implemented according to agreed criteria.
To act as Pharmacy lead for the management of High Cost Drugs, representing the Trust at High Cost Drugs meetings between commissioners and the Trust and to advise the Trust Drugs & Therapeutics Committee (DTC) on the impact of NICE Technology Appraisals
To develop and implement an annual programme of cost improvement within the service to ensure end of year financial balance. Ensure that the programme identifies ongoing cost reduction opportunities
Our vision is to provide outstanding care for every patient. Patient care is at the heart of what we do at our three sites: Basingstoke and North Hampshire Hospital, Royal Hampshire County Hospital in Winchester and Andover War Memorial Hospital. Hampshire Hospitals NHS Foundation Trust provides medical and surgical services to a population of approximately 600,000 people across Hampshire and parts of West Berkshire.
Our cultural ambition is to have a culture that places people at the heart of all we do, where we all belong, and where learning, improvement and excellence thrive.
We provide specialist services to people across the UK and internationally. We are one of only two centres in the UK treating pseudomyxoma peritonei (a rare form of abdominal cancer) and we are leaders in the field of tertiary liver cancer and colorectal cancer.
The trust employs more than 9,000 staff and has a turnover of over £500 million a year. As a Foundation Trust, we are directly accountable to our members through the governors. The Council of Governors represent the interests of their constituencies and influence the future plans of the Foundation Trust.
Tackling Climate Change: Hampshire Hospitals aims to embed sustainability and net zero carbon principles into the delivery of care across all its services. To find out more, search HHFT Climate Action orcontactclimateaction@hhft.nhs.uk.
· To lead, develop, deliver and evaluate the process for approval and appropriate use of High Cost Drugs within the Trust.
· To liaise with Trust staff, NHSE South pharmacists and other commissioners to ensure that any relevant financial and implementation issues for NICE Technology Appraisal Guidance are identified and articulated at an early stage.
· To support the business planning and challenge process for high-cost and specialist medicines and ensure that national commissioning policies and protocols for those high-cost treatments that sit outside of NICE recommendations are implemented according to agreed criteria.
· To act as Pharmacy lead for the management of High Cost Drugs, representing the Trust at High Cost Drugs meetings between commissioners and the Trust and to advise the Trust Drugs & Therapeutics Committee (DTC) on the impact of NICE Technology Appraisals
· To develop and implement an annual programme of cost improvement within the service to ensure end of year financial balance. Ensure that the programme identifies ongoing cost reduction opportunities.
This advert closes on Thursday 11 Dec 2025